BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22407852)

  • 1. RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group.
    Sano H; Shimada A; Taki T; Murata C; Park MJ; Sotomatsu M; Tabuchi K; Tawa A; Kobayashi R; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y
    Int J Hematol; 2012 May; 95(5):509-15. PubMed ID: 22407852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia.
    Al-Kzayer LF; Sakashita K; Al-Jadiry MF; Al-Hadad SA; Ghali HH; Uyen le TN; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Sughayer MA; Rihani R; Madanat FF; Inoshita T; Kamata M; Koike K
    Pediatr Blood Cancer; 2015 Dec; 62(12):2157-61. PubMed ID: 26222068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group.
    Shimada A; Taki T; Koga D; Tabuchi K; Tawa A; Hanada R; Tsuchida M; Horibe K; Tsukimoto I; Adachi S; Kojima S; Hayashi Y
    Int J Hematol; 2012 Oct; 96(4):469-76. PubMed ID: 22915059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.
    Bowen DT; Frew ME; Hills R; Gale RE; Wheatley K; Groves MJ; Langabeer SE; Kottaridis PD; Moorman AV; Burnett AK; Linch DC
    Blood; 2005 Sep; 106(6):2113-9. PubMed ID: 15951308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy 11 as an isolated abnormality in acute myeloid leukemia is associated with unfavorable prognosis but not with an NPM1 or KIT mutation.
    Alseraye FM; Zuo Z; Bueso-Ramos C; Wang S; Medeiros LJ; Lu G
    Int J Clin Exp Pathol; 2011 Apr; 4(4):371-7. PubMed ID: 21577323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of
    Mustafa Ali MK; Williams MT; Corley EM; AlKaabba F; Niyongere S
    Leuk Lymphoma; 2023 May; 64(5):962-971. PubMed ID: 37042657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study Group.
    Sano H; Shimada A; Tabuchi K; Taki T; Murata C; Park MJ; Ohki K; Sotomatsu M; Adachi S; Tawa A; Kobayashi R; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y
    Int J Hematol; 2013 Oct; 98(4):437-45. PubMed ID: 23979985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.
    Goemans BF; Zwaan CM; Miller M; Zimmermann M; Harlow A; Meshinchi S; Loonen AH; Hählen K; Reinhardt D; Creutzig U; Kaspers GJ; Heinrich MC
    Leukemia; 2005 Sep; 19(9):1536-42. PubMed ID: 16015387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemia.
    Yang X; Qian J; Sun A; Lin J; Xiao G; Yin J; Chen S; Wu D
    Clin Biochem; 2013 May; 46(7-8):579-83. PubMed ID: 23313659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical Significance of RAS Gene Mutations in Patients with Acute Myeloid Leukemia].
    Wei JF; Qiu HY; Chen Z; Miao L; Wang Y; Zhao LD; Cai ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1391-1396. PubMed ID: 36208240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
    Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
    Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia.
    Paulsson K; Horvat A; Strömbeck B; Nilsson F; Heldrup J; Behrendtz M; Forestier E; Andersson A; Fioretos T; Johansson B
    Genes Chromosomes Cancer; 2008 Jan; 47(1):26-33. PubMed ID: 17910045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia.
    Park HD; Lee SH; Sung KW; Koo HH; Jung NG; Cho B; Kim HK; Park IA; Lee KO; Ki CS; Kim SH; Yoo KH; Kim HJ
    Ann Hematol; 2012 Apr; 91(4):511-7. PubMed ID: 21901340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of KRAS mutations in adult Korean patients with acute myeloid leukemia.
    Park MJ; Park SH; Park PW; Seo YH; Kim KH; Jeong JH; Kim MJ; Ahn JY; Lee JH; Park J; Hong J
    Int J Hematol; 2013 Nov; 98(5):549-57. PubMed ID: 24105326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic PTPN11 mutations in childhood acute myeloid leukaemia.
    Tartaglia M; Martinelli S; Iavarone I; Cazzaniga G; Spinelli M; Giarin E; Petrangeli V; Carta C; Masetti R; Aricò M; Locatelli F; Basso G; Sorcini M; Pession A; Biondi A
    Br J Haematol; 2005 May; 129(3):333-9. PubMed ID: 15842656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
    Kiyoi H; Naoe T; Nakano Y; Yokota S; Minami S; Miyawaki S; Asou N; Kuriyama K; Jinnai I; Shimazaki C; Akiyama H; Saito K; Oh H; Motoji T; Omoto E; Saito H; Ohno R; Ueda R
    Blood; 1999 May; 93(9):3074-80. PubMed ID: 10216104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia.
    Christiansen DH; Andersen MK; Desta F; Pedersen-Bjergaard J
    Leukemia; 2005 Dec; 19(12):2232-40. PubMed ID: 16281072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of Coexisting Gene with NRAS in Acute Myeloid Leukemia].
    Sheng YP; Hua HY; Chao HY; Zhu WY; Wang ZQ; Zhang Y; Zhou Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):351-356. PubMed ID: 35395962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.
    Matsuo H; Yoshida K; Nakatani K; Harata Y; Higashitani M; Ito Y; Kamikubo Y; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Miyano S; Meggendorfer M; Haferlach C; Ogawa S; Adachi S
    Blood Adv; 2020 Oct; 4(19):4623-4631. PubMed ID: 32991719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group.
    Shimada A; Taki T; Tabuchi K; Taketani T; Hanada R; Tawa A; Tsuchida M; Horibe K; Tsukimoto I; Hayashi Y
    Pediatr Blood Cancer; 2008 Feb; 50(2):264-9. PubMed ID: 17763464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.